The treatment of patients with melanoma using interleukin-2, interleukin-4 and tumor infiltrating lymphocytes.
D002985:Clinical Protocols; D003131:Combined Modality Therapy; D006801:Humans; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000627:therapeutic use*; D015847:Interleukin-4 / Q000627:therapeutic use*; D016246:Lymphocytes, Tumor-Infiltrating / Q000637:transplantation*; D008545:Melanoma / Q000188:drug therapy / Q000628:therapy*; D014161:Transduction, Genetic
D007376:Interleukin-2; D015847:Interleukin-4